Janet Pope
0000-0003-1479-5302
University of Western Ontario
10 papers found
Refreshing results…
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
Results From the 2020 Canadian Rheumatology Association’s Workforce and Wellness Survey
Corrigendum to: Patient and Rheumatologist Perspectives on Tapering DMARDs in Rheumatoid Arthritis: A Qualitative Study
Current Treatment Strategies in Rheumatoid Arthritis After Methotrexate Are Not Enough to Maintain Sustained Remission: There Is No Holy Grail!
Patient and rheumatologist perspectives on tapering DMARDs in rheumatoid arthritis: a qualitative study
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis
Encounters with Rheumatologists in a Publicly Funded Canadian Healthcare System: A Population-based Study
Missing publications? Search for publications with a matching author name.